COTY Skincare Portfolio and Financial Overview

4Q23 AND FY23 OUTLOOK 4Q23 EXPECT Q4 LFL SALES GROWTH OF CORE BUSINESS RELATIVELY CONSISTENT WITH FYTD GROWTH +10% NO IMPACT FROM RUSSIA EXIT IN Q4 AT CURRENT RATES, EXPECT Q4 FX HEADWINDS ON REVENUES IN LSD % EXPECT MODEST Q4 ADJ GROSS MARGIN EXPANSION EXPECT Q4 ADJ EPS OF BREAKEVEN TO $0.01 FY23 NOW EXPECTS FY23 REVENUES FOR THE CORE BUSINESS, ADJUSTING FOR THE IMPACT OF THE RUSSIA EXIT, TO GROW 9-10% LFL WHICH REFLECTS A SIGNIFICANT INCREASE FROM THE COMPANY'S ORIGINAL OUTLOOK FOR 6-8% CORE LFL GROWTH (ADJUSTING FOR THE IMPACT OF THE RUSSIA EXIT) CONTINUE TO EXPECT MODEST GROSS MARGIN EXPANSION YOY CONTINUES TO TARGET FY23 ADJUSTED EBITDA OF $955-965M BASED ON CURRENT FX RATES, IMPLYING ~50BPS OF ADJUSTED EBITDA MARGIN EXPANSION AND OVER 150BPS OF ADJUSTED OPERATING MARGIN EXPANSION TOTAL FY23 ADJ EPS, INCLUDING EQUITY SWAP, EXPECTED TO BE $0.52-0.53, UP >85% YOY, BASED ON CURRENT STOCK PRICE INCREASING FY23 ADJ EPS OUTLOOK, EXCLUDING MARK TO MARKET FOR EQUITY SWAP, TO $0.38-0.39 FROM PREVIOUS $0.35-0.36, REFLECTING ~35% GROWTH YOY COTY * Reflects current EUR/USD of ~1.10 and GBP/USD of ~1.25 CONTINUE TO TARGET FURTHER REDUCTION IN LEVERAGE TOWARD ~3X EXITING CY23 AND ~2X EXITING CY25 29

View entire presentation